June 2026
The US drug discovery market size was evaluated at USD 26.24 billion in 2025 and is predicted to hit around USD 63.02 billion by 2035, growing at a CAGR of 9.16%.
June 2026
The global drug discovery market size was evaluated at USD 71.89 billion in 2025 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
May 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
May 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
May 2026
The global computational medicine and drug discovery software market size was evaluated at USD 10.90 billion in 2025 and is predicted to hit around USD 60.52 billion by 2035, growing at a CAGR of 18.70%.
April 2026
The global drug discovery informatics market size is estimated at USD 4.81 billion in 2025 and is projected to surpass around USD 13.68 billion by 2035 at a CAGR of 11.02%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
January 2026
The generative AI in drug discovery market size reached USD 260.56 million in 2025 and is estimated to hit around USD 2,724.15 million by 2035, at a CAGR of 26.45%.
November 2025
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 6.93 billion in 2025 with a solid CAGR of 9.90%.
January 2025
The drug discovery services market size was estimated at USD 21.26 billion in 2024 and is expected to hit around USD 79.71 billion by 2034, growing at a CAGR of 14.13% from 2025 to 2034.
January 2025
The global drug discovery outsourcing market size was valued at USD 4.15 billion in 2024 and is projected to hit around USD 8.43 billion by 2034 with a CAGR of 7.34%.
March 2026
The global computer-aided drug discovery market size is projevted to hit around USD 14.38 billion by 2035 from USD 4.72 billion in 2025 with a CAGR of 11.78%.
March 2026
The global intravenous iron drugs market size was valued at USD 3.84 billion in 2025 and is expected to attain around USD 8.82 billion by 2035 at a CAGR of 8.67%.
March 2026
The global muscle relaxant drugs market size is estimated to hit around USD 7.64 billion by 2035 increasing from USD 4.80 billion in 2025, with a CAGR of 4.76%.
February 2026
The global antitussive drugs market size was evaluated at USD 1.72 billion in 2025 and is predicted to hit around USD 2.86 billion by 2035, growing at a CAGR of 5.23%.
February 2026
The global drug of abuse testing market size was estimated at USD 14.67 billion in 2025 and is projected to hit around USD 24.14 billion by 2035, with a notable CAGR of 5.11%.
November 2025
The global duchenne muscular dystrophy drugs market size is projected to hit around USD 19.46 billion by 2034, increasing from USD 4.79 billion in 2025, with a CAGR of 16.85%.
September 2025
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
July 2025
The omega 3 prescription drugs market size was valued at USD 1.44 billion in 2024 and is projected to hit around USD 2.93 billion by 2034 with a CAGR of 7.36%.
January 2025
The global subcutaneous drug delivery devices market size was valued at USD 33.56 billion in 2024 and is projected to hit around USD 69.94 billion by 2034 with a CAGR of 7.62%.
September 2025
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
August 2025
The global rifaximin market size was estimated at USD 1.84 billion in 2024 and is projected to hit around USD 5.09 billion by 2034, with a notable CAGR of 10.72%.
August 2025
The global non-sterile liquids and suspensions market size was evaluated at USD 48.06 million in 2024 and is predicted to hit around USD 95.25 million by 2034, growing at a CAGR of 7.08%.
August 2025
The global pharmaceutical CRO market size was evaluated at USD 44.58 billion in 2024 and is projected to attain around USD 91.20 billion by 2034, with a CAGR of 7.42%.
July 2025
The global acute migraine treatment market size was valued at USD 3.46 billion in 2024 and is expected to surge around USD 10.08 billion by 2034 with a CAGR of 11.30%.
June 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
June 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
June 2026
The global drug screening market size is exhibited at USD 10.55 billion in 2025 and is anticipated to attain around USD 43.72 billion by 2035 with a CAGR of 15.28%.
June 2026
The global pharmaceutical drug delivery market size was calculated at USD 2.07 trillion in 2025 and is projected to hit around USD 3.32 trillion by 2035 with a CAGR of 4.84%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com